Ironwood Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $85,239 | $41,143 | $90,545 | $91,592 |
Gross Profit | 84,772 | 40,664 | 90,545 | 61,765 |
EBITDA | 46,645 | -27,723 | 33,802 | 27,295 |
EBIT | 46,178 | -28,202 | 33,317 | 26,788 |
Net Income | 23,599 | -37,386 | 2,256 | 3,646 |
Net Change In Cash | 85,239 | 41,143 | 90,545 | 91,592 |
Free Cash Flow | -15,070 | 19,923 | 15,214 | 9,869 |
Cash | 92,852 | 108,481 | 88,559 | 88,211 |
Basic Shares | 161,723 | 160,974 | 160,419 | 160,232 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $351,410 | $442,735 | $410,596 | $413,753 |
Gross Profit | 343,858 | 442,735 | 409,178 | 412,230 |
EBITDA | 100,243 | -924,865 | 261,438 | 233,330 |
EBIT | 98,232 | -926,440 | 260,020 | 231,807 |
Net Income | 880 | -1,002,239 | 175,065 | 528,448 |
Net Change In Cash | 351,410 | 442,735 | 410,596 | 413,753 |
Cost of Revenue | 36,074 | 257,080 | ||
Free Cash Flow | 103,407 | 183,154 | 273,627 | 261,630 |
Cash | 88,559 | 92,154 | 656,203 | 620,129 |
Basic Shares | 160,084 | 155,435 | 186,312 | 164,418 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.14 |
2025-03-31 | -$0.14 |
2024-12-31 | $0.02 |
